No description available.

Although cis-PtCl2(NH3)2 (cisplatin) has been widely used as a chemotherapeutic agent, its use can be accompanied by toxic side effects and the development of drug resistance. Consequently, much research has been focused on the discovery of novel transition metal compounds which elicit elevated cytotoxicities coupled with reduced toxic side effects and non-cross resistance. Recently, research in this lab has focused on preparing derivatives of titanocene dichloride (TDC), a highly active chemotherapeutic agent, with pendant alkylammonium groups on one or both rings. Earlier results have demonstrated that derivatives containing either cyclic or chiral alkylammonium groups had increased cytotoxic activities. This research therefore investigated a new series of TDC complexes focusing specifically on derivatives bearing cyclic and chiral alkylammonium groups. A library of ten cyclic derivatives and six chiral derivatives were synthesized and fully characterized. These derivatives have undergone in vitro testing as anti-tumour agents using human lung, ovarian, and cervical carcinoma cell lines (A549, H209, H69, H69/CP, A2780, A2780/CP and HeLa). These standard cell lines represent solid tumour types for which new drugs are urgently needed. The potencies of all of the Ti (IV) derivatives varied greatly (range from 10.8 μM - >1000 μM), although some trends were observed. In general, the dicationic analogues exhibited greater potency than the corresponding monocationic derivatives. Additionally, the cyclic analogues bearing 1,3- and 1,4-substituted pyridines displayed potent cytotoxic activities (IC50> 20 μM). It was also found at concentrations of ~30 μM that the derivatives bearing an ephedrine derived substituent were cytotoxic. Conversely, analogues substituted with piperidinyl, morpholinyl or primary alkylammonium groups were inactive (>200 μM) against the cancer cell lines assayed. / Thesis (Ph.D, Chemistry) -- Queen's University, 2008-05-14 13:18:28.141

No description available.

This thesis reports a study of the chemical stability and coordination chemistry of several antitumour metallocenes Cp2MCl2 (Cp = h5-C5H5; M = Ti 1, V 2, Nb 3, Mo 4), as well as derivatives of Cp2TiCl2 1, with nucleic acids, nucleic acid constituents and proteins. These studies were carried out in order to identify the biologically active species and more fully understand the molecular level mechanism of action of the antitumour metallocenes, in particular Cp2TiCl2 1, which is currently undergoing phase II clinical trials. The interactions of Cp2MoCl2 4 with four oligonucleotides were studied by 1H and 31P NMR spectroscopy. In 50 mM salt solutions of Cp2MoCl2 4, hydrolysis of the halide ligands occurred to give a solution with pD -2, containing a species in which both Cp rings remain metal bound for 24 h. At pD -7, partial hydrolysis of the Cp rings (-30percent) occurred after 24 h. Addition of an aqueous solution of Cp2MoCl2 4 in 50 mM salt to the self-complementary sequence d(CGCATATGCG)2, maintaining the pD at 6.0-7.0, showed no evidence for the formation of a metallocene-oligonucleotide complex and only peaks arising from hydrolysis of Cp2MoCl2 4 were detected. A similar result was obtained in titration experiments with the single stranded sequence d(ATGGTA) at pD 6.5-7.0. However, at pD 3.0, new signals assigned to a molybdocene-oligonucleotide complex(es), which was stable for hours at pD 3.0, were detected; while at pD -7 the complex is destabilised and only peaks arising from hydrolysis of Cp2MoCl2 4 were detected. Titration experiments at low pD with Cp2MoCl2 4 and the dinucleotide dCG were consistent with formation of a complex arising due to coordination of molybdenum to guanine N7 and/or cytosine N3. The results obtained showed that stable oligonucleotide adducts were not formed in 50 mM salt at pD -7 and hence it is highly unlikely that formation of molybdocene-DNA adducts in vivo is the primary action that is responsible for the antitumour properties of Cp2MoCl2 4. The rate of hydrolysis of the aromatic rings of Cp2TiX2 (X equals Cl 1, OCOCH2NH3Cl 27) and the dimethylsubstituted derivatives (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41), in aqueous solutions at pD 2-8 was studied by 1H NMR spectroscopy. Rapid hydrolysis of both the halide/glycine and Cp ligands in Cp2TiX2 (X equals Cl 1, OCOCH2NH3Cl 27) occurred and predominantly gave a precipitate at pD -7. In contrast, under the same experimental conditions, the predominant species present in aqueous solutions of (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41) at pH 2-8 contained both MeCp rings metal bound. At pD < 5, Cp2TiX2 (X equals Cl 1, OCOCH2NH3Cl 27) and (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41) formed similar complex(es) with purine nucleotides. However, at pD >5, stable adducts between nucleotides and Cp2TiX2 (X equals Cl 1, OCOCH2NH3Cl 27) were not formed. In contrast, (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41) formed complex(es) with 5'-dAMP or 5'-dGMP, which were stable for 24 h. These results suggest that formation of stable chelates between (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41) and nucleic acid constituents in vivo is possible. However, the methyl substituted derivatives 34 and 41 did not show any antitumour activity against EAT in mice when administered in either 10percentDMSO/90percentsaline or in water at pH 6.2-6.4, which suggests that the labile Cp-Ti bond present in Cp2TiCl2 1 is required for antitumour activity. The synthesis of a range of Cp substituted titanocene derivatives was investigated in an attempt to prepare derivatives with modified Cp stability in comparison to the methyl substituted derivatives. The synthesis of derivatives (CpCH2Y)2TiCl2 where Y equals ?CHO 43, ?CONMe2 44, ?NO2 45, (RCp)2TiCl2 where R equals ?COMe 46, ?COOMe 47 or ?CONMe2 48, (CpNMe2)2TiCl2 62 and (Cp(CH2)2NMe2)2TiCl2 63 was unsuccessful, due to the presence of coordinating substituents on the Cp rings and poor stability in polar, protic solvents. Hence, these derivatives were excluded from further studies. The rate of hydrolysis of the Cp rings of Cp2TiX2 (X equals Cl 1, OCOCCl3 22 and OCOCH2NH3Cl 27) in aqueous solutions, 10percentDMSO/90percentD2O and 100percent DMSO was monitored by 1H NMR spectroscopy. Rapid hydrolysis of both the carboxylate and Cp ligands of Cp2TiX2 (OCOCCl3 22 and OCOCH2NH3Cl 27) occurred in DMSO to give biologically inactive species. The rate of these reactions were concentration dependent as dilution of these samples with saline or water to give the therapeutic conditions of 10percentDMSO/90percentD2O slowed the hydrolysis chemistry. In contrast, samples of Cp2TiX2 (X equals Cl 1 and OCOCH2NH3Cl 27) dissolved in water, gave solutions containing the presumed antitumour active species in which the halide or glycine ligands have been hydrolysed but the Cp rings remain metal bound. Thus, charged X ligands may be incorporated into Cp2TiX2 and will give comparable activity to Cp2TiCl2 1 provided the samples are administered in water. The antitumour metallocenes Cp2MCl2 (M equals Ti 1, V 2, Nb 3, Mo 4) and the inactive derivative (MeCp)2TiCl2 34 were found to inhibit the relaxation of supercoiled plasmid DNA pBR322 by human topoisomerase II in vitro. These results implicated the inhibition of topoisomerase II in the mechanism of antitumour activity although there was no direct correlation between the in vitro results with biological activity against EAT in vivo. UV spectroscopy confirmed that the metallocenes Cp2MCl2 (M equals Ti 1, Mo 4) became associated with and were stabilised to hydrolysis by calf thymus DNA but not with human serum albumin. ICP-AES was used to measure the amount of metal associated with either DNA or human serum albumin after incubation with Cp2MCl2 (M equals Ti 1, Nb 3, Mo 4) and dialysis of these solution. The results confirmed that DNA stabilises or becomes associated with the metallocenes. However, errors associated with the ICP-AES measurements did not allow these results to be quantified. 1H NMR spectroscopy was used to show that the antitumour metallocene Cp2MoCl2 4 formed an adduct with glutathione 72 in the pH range 3-7 through the sulfur donor group. In comparison, the antitumour metallocenes Cp2MCl2 (M equals Ti 1, Nb 3) showed limited adduct formation with glutathione 72 at pH -3 and no adducts were detected at pH > 5.5.

This thesis reports a study of the chemical stability and coordination chemistry of several antitumour metallocenes Cp2MCl2 (Cp = h5-C5H5; M = Ti 1, V 2, Nb 3, Mo 4), as well as derivatives of Cp2TiCl2 1, with nucleic acids, nucleic acid constituents and proteins. These studies were carried out in order to identify the biologically active species and more fully understand the molecular level mechanism of action of the antitumour metallocenes, in particular Cp2TiCl2 1, which is currently undergoing phase II clinical trials. The interactions of Cp2MoCl2 4 with four oligonucleotides were studied by 1H and 31P NMR spectroscopy. In 50 mM salt solutions of Cp2MoCl2 4, hydrolysis of the halide ligands occurred to give a solution with pD -2, containing a species in which both Cp rings remain metal bound for 24 h. At pD -7, partial hydrolysis of the Cp rings (-30percent) occurred after 24 h. Addition of an aqueous solution of Cp2MoCl2 4 in 50 mM salt to the self-complementary sequence d(CGCATATGCG)2, maintaining the pD at 6.0-7.0, showed no evidence for the formation of a metallocene-oligonucleotide complex and only peaks arising from hydrolysis of Cp2MoCl2 4 were detected. A similar result was obtained in titration experiments with the single stranded sequence d(ATGGTA) at pD 6.5-7.0. However, at pD 3.0, new signals assigned to a molybdocene-oligonucleotide complex(es), which was stable for hours at pD 3.0, were detected; while at pD -7 the complex is destabilised and only peaks arising from hydrolysis of Cp2MoCl2 4 were detected. Titration experiments at low pD with Cp2MoCl2 4 and the dinucleotide dCG were consistent with formation of a complex arising due to coordination of molybdenum to guanine N7 and/or cytosine N3. The results obtained showed that stable oligonucleotide adducts were not formed in 50 mM salt at pD -7 and hence it is highly unlikely that formation of molybdocene-DNA adducts in vivo is the primary action that is responsible for the antitumour properties of Cp2MoCl2 4. The rate of hydrolysis of the aromatic rings of Cp2TiX2 (X equals Cl 1, OCOCH2NH3Cl 27) and the dimethylsubstituted derivatives (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41), in aqueous solutions at pD 2-8 was studied by 1H NMR spectroscopy. Rapid hydrolysis of both the halide/glycine and Cp ligands in Cp2TiX2 (X equals Cl 1, OCOCH2NH3Cl 27) occurred and predominantly gave a precipitate at pD -7. In contrast, under the same experimental conditions, the predominant species present in aqueous solutions of (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41) at pH 2-8 contained both MeCp rings metal bound. At pD < 5, Cp2TiX2 (X equals Cl 1, OCOCH2NH3Cl 27) and (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41) formed similar complex(es) with purine nucleotides. However, at pD >5, stable adducts between nucleotides and Cp2TiX2 (X equals Cl 1, OCOCH2NH3Cl 27) were not formed. In contrast, (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41) formed complex(es) with 5'-dAMP or 5'-dGMP, which were stable for 24 h. These results suggest that formation of stable chelates between (MeCp)2TiX2 (X equals Cl 34, OCOCH2NH3Cl 41) and nucleic acid constituents in vivo is possible. However, the methyl substituted derivatives 34 and 41 did not show any antitumour activity against EAT in mice when administered in either 10percentDMSO/90percentsaline or in water at pH 6.2-6.4, which suggests that the labile Cp-Ti bond present in Cp2TiCl2 1 is required for antitumour activity. The synthesis of a range of Cp substituted titanocene derivatives was investigated in an attempt to prepare derivatives with modified Cp stability in comparison to the methyl substituted derivatives. The synthesis of derivatives (CpCH2Y)2TiCl2 where Y equals ?CHO 43, ?CONMe2 44, ?NO2 45, (RCp)2TiCl2 where R equals ?COMe 46, ?COOMe 47 or ?CONMe2 48, (CpNMe2)2TiCl2 62 and (Cp(CH2)2NMe2)2TiCl2 63 was unsuccessful, due to the presence of coordinating substituents on the Cp rings and poor stability in polar, protic solvents. Hence, these derivatives were excluded from further studies. The rate of hydrolysis of the Cp rings of Cp2TiX2 (X equals Cl 1, OCOCCl3 22 and OCOCH2NH3Cl 27) in aqueous solutions, 10percentDMSO/90percentD2O and 100percent DMSO was monitored by 1H NMR spectroscopy. Rapid hydrolysis of both the carboxylate and Cp ligands of Cp2TiX2 (OCOCCl3 22 and OCOCH2NH3Cl 27) occurred in DMSO to give biologically inactive species. The rate of these reactions were concentration dependent as dilution of these samples with saline or water to give the therapeutic conditions of 10percentDMSO/90percentD2O slowed the hydrolysis chemistry. In contrast, samples of Cp2TiX2 (X equals Cl 1 and OCOCH2NH3Cl 27) dissolved in water, gave solutions containing the presumed antitumour active species in which the halide or glycine ligands have been hydrolysed but the Cp rings remain metal bound. Thus, charged X ligands may be incorporated into Cp2TiX2 and will give comparable activity to Cp2TiCl2 1 provided the samples are administered in water. The antitumour metallocenes Cp2MCl2 (M equals Ti 1, V 2, Nb 3, Mo 4) and the inactive derivative (MeCp)2TiCl2 34 were found to inhibit the relaxation of supercoiled plasmid DNA pBR322 by human topoisomerase II in vitro. These results implicated the inhibition of topoisomerase II in the mechanism of antitumour activity although there was no direct correlation between the in vitro results with biological activity against EAT in vivo. UV spectroscopy confirmed that the metallocenes Cp2MCl2 (M equals Ti 1, Mo 4) became associated with and were stabilised to hydrolysis by calf thymus DNA but not with human serum albumin. ICP-AES was used to measure the amount of metal associated with either DNA or human serum albumin after incubation with Cp2MCl2 (M equals Ti 1, Nb 3, Mo 4) and dialysis of these solution. The results confirmed that DNA stabilises or becomes associated with the metallocenes. However, errors associated with the ICP-AES measurements did not allow these results to be quantified. 1H NMR spectroscopy was used to show that the antitumour metallocene Cp2MoCl2 4 formed an adduct with glutathione 72 in the pH range 3-7 through the sulfur donor group. In comparison, the antitumour metallocenes Cp2MCl2 (M equals Ti 1, Nb 3) showed limited adduct formation with glutathione 72 at pH -3 and no adducts were detected at pH > 5.5.

A series of four novel halosilylsubstitued monocyclopentadienyl titanium complexes; [Si(CH3)2FCp]TiCl3 – FSiTTC, [Si(CH3)F2Cp]TiCl3 F2SiTTC, [Si(CH3)Cl2Cp]TiCl3 - Cl2SiTTC, [Si(CH3)2ClCp]TiCl3 - ClSiTTC was tested as catalytic precursors for polymerization of styrene in toluene. The maximum polymerization activity was achieved after polymerization period of 20 minutes. Activity decreased in order FSiTTC/MAO > F2SiTTC/MAO > Cl2SiTTC/MAO > ClSiTTC /MAO. Prepared polystyrenes were characterized using 13C NMR spectroscopy and DSC analysis. Syndiotacticity index of obtained PSs was determined by means of Soxhlet extraction with butan-2-one as solvent. Syndiotacticity indexes of PSs obtained by investigated catalysts possessed higher values then those obtained by standard catalysts (CpTiCl3 a Cp*TiCl3) at comparable polymerization conditions.

Bibliographische Beschreibung und Referat Frosch, W. Synthese und Reaktionsverhalten Bis(alkinyl)-Metallocen-stabilisierter monomerer Organo-Kupfer(I)-Verbindungen Technische Universität Chemnitz, Fakultät für Naturwissenschaften, Dissertation, 2001, 103 Seiten. In der vorliegenden Arbeit werden Synthese und Reaktionsverhalten von hetero-metallischen Ti(IV)-Cu(I)-Komplexen der Art {[Ti](CCR1)2}CuX {[Ti] = (h5-C5H4SiMe3)2Ti; R1 = einfach gebundener organischer Rest; X = anorganischer, organischer oder metallorganischer Rest} beschrieben. Diese Verbindungen können zwei bis fünf Übergangsmetall-Atome enthalten, welche durch verschiedene Komplex-Liganden und auf unterschiedliche Bindungsweise miteinander verknüpft sind. Zentrale Bausteine der in dieser Arbeit untersuchten Komplexe sind die metallorganischen pi-Pinzetten [Ti](CCR1)2 und der monomere Kupfer(I)-Methyl- Komplex {[Ti](CCR1)2}CuCH3. Letzterer kann in vielfältiger Weise zur Synthese verschiedener bis(h2-alkin)-stabilisierter Kupfer(I)-Verbindungen verwendet werden, welche im besonderen Interesse der vorliegenden Untersuchungen standen. Des Weiteren war das Augenmerk auf das Reaktionsverhalten von [Ti](CCR1)2 gegenüber ÜM-Komplexen von Metallen der Gruppe 12 des Periodensystems der Elemente in verschiedenen Oxidationsstufen gerichtet. Die im Rahmen dieser Arbeit durchgeführten Untersuchungen lassen sich dabei in vier Schwerpunkte gliedern: 1) Mehrfach Carboxylat-funktionalisierte Ti(IV)-Cu(I)-Komplexe: Synthese, Fest-körperstruktur und Reaktionsverhalten. 2) Reaktion von Bis(alkinyl)-Titanocenen mit Metall-Verbindungen der Gruppe 10-12 des Periodensystems der Elemente. 3) Donor-funktionalisierte Bis(alkinyl)-Titanocene und deren Reaktionsverhalten. 4) Monomeres Kupfer(I)-Methyl als synthetisches Werkzeug: Synthese einer breiten Palette unterschiedlicher Kupfer(I)-Systeme. Stichworte: metallorganisch, heterometallisch, pi-Systeme, Metallocene, Alkine, Bis(alkinyl)-Titanocene, metallorganische pi-Pinzetten, Koordinationsverbindungen, Kupfer(I), monomere Kupfer(I)-Organyle.

Bibliographische Beschreibung und Referat Frosch, W. Synthese und Reaktionsverhalten Bis(alkinyl)-Metallocen-stabilisierter monomerer Organo-Kupfer(I)-Verbindungen Technische Universität Chemnitz, Fakultät für Naturwissenschaften, Dissertation, 2001, 103 Seiten. In der vorliegenden Arbeit werden Synthese und Reaktionsverhalten von hetero-metallischen Ti(IV)-Cu(I)-Komplexen der Art {[Ti](CCR1)2}CuX {[Ti] = (h5-C5H4SiMe3)2Ti; R1 = einfach gebundener organischer Rest; X = anorganischer, organischer oder metallorganischer Rest} beschrieben. Diese Verbindungen können zwei bis fünf Übergangsmetall-Atome enthalten, welche durch verschiedene Komplex-Liganden und auf unterschiedliche Bindungsweise miteinander verknüpft sind. Zentrale Bausteine der in dieser Arbeit untersuchten Komplexe sind die metallorganischen pi-Pinzetten [Ti](CCR1)2 und der monomere Kupfer(I)-Methyl- Komplex {[Ti](CCR1)2}CuCH3. Letzterer kann in vielfältiger Weise zur Synthese verschiedener bis(h2-alkin)-stabilisierter Kupfer(I)-Verbindungen verwendet werden, welche im besonderen Interesse der vorliegenden Untersuchungen standen. Des Weiteren war das Augenmerk auf das Reaktionsverhalten von [Ti](CCR1)2 gegenüber ÜM-Komplexen von Metallen der Gruppe 12 des Periodensystems der Elemente in verschiedenen Oxidationsstufen gerichtet. Die im Rahmen dieser Arbeit durchgeführten Untersuchungen lassen sich dabei in vier Schwerpunkte gliedern: 1) Mehrfach Carboxylat-funktionalisierte Ti(IV)-Cu(I)-Komplexe: Synthese, Fest-körperstruktur und Reaktionsverhalten. 2) Reaktion von Bis(alkinyl)-Titanocenen mit Metall-Verbindungen der Gruppe 10-12 des Periodensystems der Elemente. 3) Donor-funktionalisierte Bis(alkinyl)-Titanocene und deren Reaktionsverhalten. 4) Monomeres Kupfer(I)-Methyl als synthetisches Werkzeug: Synthese einer breiten Palette unterschiedlicher Kupfer(I)-Systeme. Stichworte: metallorganisch, heterometallisch, pi-Systeme, Metallocene, Alkine, Bis(alkinyl)-Titanocene, metallorganische pi-Pinzetten, Koordinationsverbindungen, Kupfer(I), monomere Kupfer(I)-Organyle.

Automation plays an integral role in our daily lives. From transportation to agriculture, we rely on robots and programs to assist in accomplishing tasks. Chemistry is no except with the deployment of high throughput screening and the recent machine-led reaction discovery, there is increased interest to integrate artificial intelligence and robotics beyond medicinal and synthetic organic chemistry. The addition of automation to mechanistic studies can improve the method in which reactions are understood experimentally and fundamentally. Chapter 1 introduces the basics of reaction chemistry. As we are interested in how the reaction occurs, for this work, there is a natural bias towards understanding kinetic behaviour. Chronograms obtained through mass spectrometry facilitate understanding of kinetics. The introduction of mass spectrometry in this chapter establishes the foundation of this technique for the subsequent experimental chemistry chapters. Chapter 2 investigates the reduction and subsequent oxidation of titanocene, generating a complex mixture of oxidized products. During this investigation, an interesting and rare methyl abstraction event occurred that led to the deuterium label study to understand a radical-based oxo-titanium reaction. This was made possible by Pressurized Sample Infusion Electrospray Ionization Mass Spectrometry (PSI-ESI-MS) coupled with a smartphone colorimetry technique developed herein known as ColorPixel. In Chapter 3 we explore the integration of machine learning with reaction monitoring. The attempt to classify reaction roles based on kinetic traces was done to automate the process of identifying important species in a reaction. Often there is a large amount of data from a PSI-ESI-MS experiment, but it is time-consuming to pick out the most important species. Implementing machine learning for reaction role classification can ease this process from taking three months to accomplish to one day. This chapter also outlines the development of Kendrick, an automated reaction sampler. Combined, these tools have the potential to impact reaction monitoring through robotic assistance and can speed up the process of reaction quantification through automated processing platforms to handle the streams of data. Chapter 4 starts with the implementation of a lightweight mass spectrometry library, Spectra.ly, that is suitable for any developers using python. This platform establishes a firm foundation that can enable developers to build complex programs using simple code. This chapter also describes the collaboration project PythoMS and the development process for this framework. In addition to the framework, the chapter also describes the development of two pieces of processing software: Sinatra – a cloud-ready EDESI processing platform, and AutoMRM – a cloud-based Multiple Reaction Monitoring method development web application. / Graduate

En vue de contourner les phénomènes de chimiorésistance et l’apparition d’effets secondaires sévères engendrés par les traitements à base de platine, nous avons développé des agents thérapeutiques à base d’autre métaux.Mon premier projet repose sur l’élaboration de complexes d’or(I) traçables possédant des propriétés anticancéreuses et anti-inflammatoires. Afin d’apporter des informations préliminaires sur leur mécanisme d’action, deux sondes imageantes ont été introduites : soit une coumarine, soit un BODIPY. Ainsi, deux séries de complexes d’or(I) ont été synthétisées. Trois d’entre eux présentent cette double activité thérapeutique dont deux pouvant être traçables in vitro.Mon deuxième projet est axé sur le développement de complexes de titane stables et solubles en milieu auqueux. Afin d’améliorer la cytotoxicité de ces titanocènes, notre stratégie a consisté à introduire un second métal thérapeutique au sein de ces structures. Cette étude a mené à deux nouveaux titanocènes possédant une activité anti-proliférative submicromolaire sur différentes lignées de cellules cancéreuses ainsi qu’une activité antitumorale in vivo, sans induire de signe de toxicité chez la souris saine. Afin d’étudier leur mécanisme d’action, l’introduction de deux modalités d’imageries a été envisagée sur ces complexes : l’imagerie optique ou l’imagerie TEP. Un complexe présentant une sonde fluorescente a été synthétisé et une voie de radiomarquage a été développée. / We have developed non-platinum therapeutic agents in order to avoid chemoresistance phenomena and severe side effects caused by treatments based on this metal.My first project relies on the development of trackable gold(I)-complexes displaying both anticancer and anti-inflammatory properties. An imaging probe was introduced on these complexes – either a coumarin or a BODIPY – in order to give preliminary information on their mechanism of action. Thus, two series of gold(I) complexes were synthesized. Three of these compounds presents this double therapeutic activity, two of them can be trackable in vitro.My second project is focused on the development of stable and soluble titanium complexes in water. We decided to introduce a second therapeutic metal into these structures in order to improve the cytotoxicity of these titanocenes. This study led to two new titanocenes displaying submicromolar anti-proliferative activity on different cancer cell lines along with an antitumoral activity in vivo, without inducing any sign of toxicity on healthy mice. We decided to introduce two imaging modalities – optical or PET imaging – into these complexes for investigating their mechanism of action. A complex bearing a fluorescent probe was synthesized and a radiolabeling method was developed.